No abstract available
MeSH terms
-
Administration, Oral
-
Anticoagulants / administration & dosage
-
Anticoagulants / adverse effects
-
Benzimidazoles* / administration & dosage
-
Benzimidazoles* / adverse effects
-
Dabigatran
-
Drug Contamination
-
Drug Monitoring / methods*
-
Food-Drug Interactions
-
Hemorrhage / chemically induced
-
Hemorrhage / prevention & control
-
Heparin / administration & dosage
-
Heparin / adverse effects*
-
Humans
-
Hypersensitivity / etiology
-
Hypersensitivity / prevention & control
-
Injections, Subcutaneous / adverse effects
-
Necrosis / etiology
-
Necrosis / prevention & control
-
Osteoporosis / chemically induced
-
Osteoporosis / prevention & control
-
Skin Diseases / chemically induced
-
Skin Diseases / prevention & control
-
Subcutaneous Tissue / drug effects
-
Thrombocytopenia / chemically induced
-
Thrombocytopenia / prevention & control
-
Warfarin* / administration & dosage
-
Warfarin* / adverse effects
-
beta-Alanine / administration & dosage
-
beta-Alanine / adverse effects
-
beta-Alanine / analogs & derivatives*
Substances
-
Anticoagulants
-
Benzimidazoles
-
beta-Alanine
-
Warfarin
-
Heparin
-
Dabigatran